GlassScriptPhysician profile
Abdus S Soudagar
NPI 1043447774
$5,150.94
in general payments reported to CMS, 2019-2025
7 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $48.14 · 2022: $1,495 · 2023: $2,671 · 2024: $295 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,700 · Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,700.00 |
| Food and Beverage | $1,405.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,557.71 | 2019-2025 | Exalt Model D, Axios, Spyglass |
| Endogastric Solutions, INC | $170.28 | 2022-2023 | Esophyx |
| Cook Medical LLC | $139.87 | 2023 | Hemospray |
| Apollo Endosurgery US INC | $136.25 | 2023 | Overstitch Endoscopic Suturing System |
| Medtronic, INC. | $119.34 | 2023 | Prodigi |
| Conmed Corporation | $15.37 | 2024 | Conmed Biliary |
| Erbe USA INC | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdus Soudagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.